Purchase Order HHSN261201700272P
Award Date 6/6/17
Potential Completion Date 7/6/17
Potential Value $96K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price delivery order awarded by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc., a for-profit manufacturer of genetic analysis instruments and reagents. The $91,730.47 contract is for the provision of biological kits, Illumina sequencing systems, and related supplies and services. Illumina has a history of providing its proprietary sequencing platforms and consumables to support genomic research...
- This is a firm fixed-price delivery order awarded by the National Cancer Institute, a civilian agency, to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis equipment and consumables. The order, worth $20,548.50, is for the provision of Illumina's proprietary sequencing systems, reagents, and related items to support genomic research and diagnostics. Illumina has been a prime and subcontractor to numerous federal agencies, including the NIH, CDC, USDA, and VA, for...
- This is a firm fixed price delivery order awarded by the National Cancer Institute (NCI), a civilian agency, to Illumina, Inc., a for-profit manufacturer of genetic sequencing instruments and reagents. The $90,461.80 order is for reagents and consumables to support the agency's genomic sequencing and analysis needs. Illumina has previously received other prime federal contracts and subcontracts from agencies like the NIH, CDC, USDA, and VA to provide a range of sequencing systems and related...
- This firm fixed-price delivery order was awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Illumina, Inc., a for-profit manufacturer of sequencing and array-based genomics analysis products. The $28,701.70 contract is for the provision of various Illumina sequencing instruments, reagents, and related services. This award does not have a set-aside designation. Through prior prime and subcontract awards, Illumina has supported...
- This is a firm fixed price delivery order awarded by the National Cancer Institute, an agency of the U.S. Department of Health and Human Services, to Illumina, Inc. for $3,689.79. Illumina, a manufacturer of genome sequencing and analysis instruments and reagents, will provide its proprietary sequencing systems, consumables, and support services to the agency. This order is part of a larger Indefinite Delivery Contract worth up to $3.3 million that Illumina holds with the Department of the...
- This is a firm fixed price delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Illumina, Inc. for $12,081.90. The contract is not designated as a set-aside. Illumina, a manufacturer of genetic sequencing equipment and supplies, will provide goods and services to support genomic sequencing and analysis for research and diagnostics purposes. The award is likely part of a larger Indefinite...
- This is a firm fixed price delivery order awarded to Illumina, Inc. by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services. The $96,655.25 award is for the provision of biological kits, Illumina sequencing systems and related products and services. No set-aside provisions were used. Illumina is a manufacturer and provider of genetic and genomic analysis solutions, and has a history of supporting federal agencies like the NIH, CDC, USDA, and VA...
- This $111,697.92 firm fixed-price purchase order was awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency under the Department of Health and Human Services, to Illumina, Inc. for DNA analysis kits. The contract is not associated with a set-aside or larger contract vehicle. Illumina is a manufacturer of sequencing and array-based genomic analysis solutions, and has provided a range of sequencing instruments, reagents, and services to support research and...
- This is a firm fixed price purchase order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Child Health and Human Development to Illumina, Inc., a for-profit manufacturer of genetic sequencing and analysis products. The $105,592.48 award does not have a set-aside designation. Illumina has previously received prime federal contracts and sub-grants from various agencies like the NIH, Centers for Disease Control, Department of...
- This is a firm fixed-price purchase order awarded by the National Human Genome Research Institute, an agency within the National Institutes of Health, to Illumina, Inc., a biotechnology company specializing in genetic sequencing and genomic analysis technologies. The $12,103.44 contract has a completion date of September 29, 2025 and does not utilize a set-aside designation. Illumina provides a range of genomic sequencing platforms, reagents, consumables, and maintenance services to support...